High materiality7/10
Revolution Medicines price target raised to $179 from $151 at Bernstein
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RVMD received an analyst target update from Bernstein.
- Target raised to $179; current price $211.74.
Key facts
- 01
Target: $179
- 02
Posted price: $211.74
- 03
Analyst firm: Bernstein
- 04
Analyst: Jeffrey Walch
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.